Drug Optimization & Chemical Structure Modification of Antiseizure
Date
2011-06-01
Authors
Walaa Hemedat
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
<p>Gabapentin which is chemically known as 1-aminomethyl-1-cyclohexaneacetic acid and its structure is shown below is a very well known pharmaceutical drug useful for the treatment of epilepsy and other cerebral disorders. The medicine suffers form several disadvantages and low bioactivity. This presentation covers an overview about the drug synthesis, application and new ways of structure modification that could enhance the bioactivity of Gabapentin and reduces it side effects. The suggested chemical modification of Gabapentin is expected to increase its permeability to blood brain barrier.</p>
<p>Gabapentin which is chemically known as 1-aminomethyl-1-cyclohexaneacetic acid and its structure is shown below is a very well known pharmaceutical drug useful for the treatment of epilepsy and other cerebral disorders. The medicine suffers form several disadvantages and low bioactivity. This presentation covers an overview about the drug synthesis, application and new ways of structure modification that could enhance the bioactivity of Gabapentin and reduces it side effects. The suggested chemical modification of Gabapentin is expected to increase its permeability to blood brain barrier.</p>
<p>Gabapentin which is chemically known as 1-aminomethyl-1-cyclohexaneacetic acid and its structure is shown below is a very well known pharmaceutical drug useful for the treatment of epilepsy and other cerebral disorders. The medicine suffers form several disadvantages and low bioactivity. This presentation covers an overview about the drug synthesis, application and new ways of structure modification that could enhance the bioactivity of Gabapentin and reduces it side effects. The suggested chemical modification of Gabapentin is expected to increase its permeability to blood brain barrier.</p>